Omega-6 to Omega-3 Ratio: What Your Gut Wall Is Built From

Your gut lining turns over in days. It builds each new cell membrane from fats you ate recently, so last week’s fats are the raw material of the wall. Tip the omega-6 to omega-3 ratio heavily toward omega-6, the fat in industrial seed oils, and the membrane’s raw material leans toward starting inflammation instead of shutting it down.

An antibody test kit reported a molecule that helps end inflammation, called resolvin D1, in human blood at more than 2,000 pg/ml. Mass spectrometry, the accurate method, puts the real figure near 30 (Schebb et al., 2022). If a lab number has ever told you your inflammation was under control, keep that gap in mind, because the omega-6 to omega-3 ratio of your gut wall is a better target than most of what gets tested.

Watch Your Gut Wall Is What You Fried Last Week above for the full case from The Angry Gut, written by Dr. Gurpreet Singh Padda, MD, MBA, MHP, with Ami Michelle Grimes. Here the questions are practical. What can be measured about the fat in your gut? Which measurements mislead? And what actually repairs the terrain?

How does the omega-6 to omega-3 ratio affect your gut lining?

Your gut is the first brain, tied by the vagus nerve to the second brain in your skull. Its lining turns over in days. Each new cell membrane is built from fats you ate recently. Those membranes are not packaging. They hold the raw material for signals that start inflammation and for those that shut it down.

Tip the ratio heavily toward omega-6, the fat that dominates industrial seed oils, and that raw material leans toward ignition. That is metaflammation written into a single cell wall. It is the same engine behind the insulin resistance and aging that bring most people to regenerative medicine. It is why metabolic inflammation is the frame we work from.

The ratio is rarely a personal choice. Omega-6 oil is the cheapest fat in a commercial kitchen because the crops behind it are subsidized. Whole-fat dairy left many diets because a guideline said to remove it. Policy builds the terrain long before preference does.

A deficit you can measure is not a deficit you can feed

The cleanest fat finding in gut medicine looks like an easy fix. Colon mucus is waterproofed by a fat called phosphatidylcholine. In ulcerative colitis, mucus held 745 ± 148 pmol per 100 µg protein, against 2,790 in healthy controls. Crohn’s disease sat close to normal (Braun et al., 2009).

So a delayed-release phosphatidylcholine, made to release in the colon, was built to replace it, and phase 3 was stopped because it was not working. At twelve weeks, placebo reached deep remission in 13.5% of patients. The two drug groups reached 14.2% and 9.7% (Dignass et al., 2023).

The reason matters for every lab result you will ever be handed. A survey of fats in inflamed lining tagged 584 of them. It concluded that the colon mostly makes its own phosphatidylcholine instead of importing it (Moe et al., 2025). Patients in remission looked like healthy controls. The fat loss tracked the inflamed state, not the grocery list. Low in the tissue does not mean short in the diet.

Does a blood fat test tell you what is in the gut wall?

Mice were fed three levels of EPA and DHA for five weeks. Gut tissue EPA rose from 0.2-0.6% at baseline to 1.6-4.3% on the richest diet. The blood marker tracked the tissue, with correlations of r > 0.91 (Gurzell et al., 2014). That is mouse data across a wide dose range. But it undercuts the claim that a blood fat profile, such as an omega-3 index test, says nothing about tissue.

Now the human twist. Biopsies came from 69 people with ulcerative colitis and 69 matched controls. Inflamed lining showed the expected picture: more arachidonic acid, less EPA, and a higher ratio between them. The same tissue also held more DHA, an omega-3, and less linoleic acid, the omega-6 everyone blames. Diets did not differ between the groups (Pearl et al., 2013).

Inflamed tissue sorts its fats. It is not a mirror of the plate. A ratio read from blood is a useful terrain signal and a poor verdict on its own. It belongs next to the rest of a full metabolic audit, not in place of it.

Are resolvin and inflammation lipid tests accurate?

The body switches inflammation off on purpose using fat-based messengers: resolvins, protectins, maresins, lipoxins. As drugs they work. Whether your own tissues make them at working levels is where the measurements fall apart.

The kit problem is cross-reaction. Antibody tests pick up neighboring fats and report the total. That is how a figure near 30 became one above 2,000. In inflamed human colon tested properly, the messengers built from omega-6 arachidonic acid could be measured. Every EPA-based one fell below the limit the test can count. A 2026 method paper validated tests for nineteen messengers. It found none at all in stimulated whole blood, the sample most clinical studies draw. Yet it found them forming in quantity in certain immune cell setups (Hofstetter et al., 2026).

The cells can make these molecules. No one has shown your gut holds them at working levels. This is a mechanism-level position. We act on what membranes are built from, because that part can be measured and changed.

What does C15:0 from dairy fat tell you?

Some bottlenose dolphins in human care developed a condition like metabolic syndrome. They carried the odd-chain saturated fat C17:0 at 0.3 ± 0.1%, against 1.3 ± 0.4% in dolphins with low insulin. Among the dairy products tested, butter carried 423mg/100g of C17:0, and nonfat dairy products had none detectable (Venn-Watson et al., 2015).

In people, the evidence is a link, not proof. Pooling 16 forward-looking cohorts, people with more pentadecanoic acid (C15:0) in their blood developed type 2 diabetes less often. The hazard ratio of 0.80 held after adjusting for body fat (Imamura et al., 2018). Two cautions. C15:0 is the standard marker of dairy fat intake, so the signal may belong to the food. And the scientist calling C15:0 an essential fat with a named deficiency founded the company that sells it. That claim rests on cell, animal and cohort evidence, not a human trial (Venn-Watson, 2024).

The practical conclusion is whole-fat dairy and fish on a plate, not a powder.

How do you improve your omega-6 to omega-3 ratio?

Repair follows the turnover. A lining rebuilt every few days responds to a steady change in raw material, meal after meal. That means moving the cooking fat away from industrial seed oil. It means cutting food from fryers you do not control. And it means bringing back fish fat and whole-fat dairy. None of it needs a supplement, and none of it depends on a test that overcounts.

The behavior piece is where most plans fail. People keep the capsule and keep the fryer, because the capsule asks nothing of the week. The body will not honor that trade. Membranes are built from the bulk of what arrives, not from one softgel.

For every study with its full numbers, and what each shows and does not show, the Chapter 8 Deep Dive goes further. It includes the strongest case against this position. The wall’s protein frame is covered in why collagen is the wall, not the paint. How to increase nitric oxide follows the blood supply those membranes depend on. The same fats shape the brain, as how the modern plate sets the brain on fire explains.

For more information, get our free guide to knee pain and treatment options.

Frequently asked questions

What is a healthy omega-6 to omega-3 ratio?

No trial has validated a single target number for the gut. What the evidence supports is direction. A membrane built mostly from omega-6 fat carries more raw material for signals that start inflammation. The practical move is less industrial seed oil and fried food, and more fish fat. Keep it up long enough for a lining that turns over in days. Why inflammation accelerates aging shows where that terrain leads.

Is an omega-3 index test a good marker of gut tissue?

In mice fed a range of omega-3 doses, blood fats tracked gut tissue closely, with correlations above 0.91. Human inflamed tissue is less obedient. It held more DHA and less linoleic acid than healthy tissue, even though diets did not differ. Treat the result as a terrain signal alongside other markers, not a verdict. How inflammation biomarkers are read in context covers the same principle.

Is pentadecanoic acid (C15:0) an essential fatty acid?

That is a hypothesis, an unproven idea, not an established fact. Higher blood C15:0 tracks with lower type 2 diabetes across cohorts. But C15:0 is also the standard marker of dairy fat intake. And the leading voice for calling it essential founded the company selling it. The evidence is cell, animal and observational work. Whole-fat dairy is the food-first answer. Why your brain is built from fat makes a related case.

Can you get tested for resolvins?

Commercial antibody kits sold to labs cross-react with neighboring fats. That is how one resolvin measured above 2,000 pg/ml by kit and near 30 by mass spectrometry. Validated methods have not found these molecules in stimulated whole blood. A result from such a panel says little about your gut. Measuring what your diet is building is more useful. Why the same treatment heals one person and fails another explains the terrain view.

Does taking phosphatidylcholine help ulcerative colitis?

The shortfall in colon mucus is real. But a delayed-release phosphatidylcholine built to replace it was stopped in phase 3 because it was not working. Fat profiling suggests the colon makes most of its own supply. So feeding more raw material does not restart a broken production line. Any treatment decision belongs with your physician. How the gut drives joint pain follows the same lining outward.

Why is a high omega-6 to omega-3 ratio bad?

Your gut lining rebuilds itself every few days from the fats you recently ate. When those fats lean heavily toward omega-6, each new cell membrane carries more raw material for signals that start inflammation. It carries less for the signals that shut it down. That is metaflammation written into a single cell wall, the same engine behind insulin resistance and aging.

What foods high in omega-6 should you avoid?

The main source is industrial seed oil, the cheapest fat in a commercial kitchen. Food from fryers you do not control adds more. Move your own cooking fat away from seed oil and cut back on food fried by restaurants and food makers. Then bring back fish fat and whole-fat dairy. That gives the lining better raw material to rebuild from, meal after meal.

Do omega-3 capsules fix the omega-6 to omega-3 ratio?

Not on their own. Cell membranes are built from the bulk of the fat that arrives, not from one softgel. Many people keep the capsule and keep the fryer, because the capsule asks nothing of the week. The repair is changing the cooking fat and the fried food, then eating fish and whole-fat dairy. None of it needs a supplement.

Sources

1. Braun, A., Treede, I., Gotthardt, D., Tietje, A., Zahn, A., Ruhwald, R., Schoenfeld, U., Welsch, T., Kienle, P., Erben, G., Lehmann, W.-D., Fuellekrug, J., Stremmel, W., & Ehehalt, R. (2009). Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis. Inflammatory Bowel Diseases, 15(11), 1705–1720. https://doi.org/10.1002/ibd.20993
2. Dignass, A., Stremmel, W., Horynski, M., Poyda, O., Armerding, P., Felle, T., Hoffmann, J., Klaus, J., Ludwig, D., Schmidt, C., Simon, M., Thomann, A., Zeuzem, S., & Bokemeyer, B. (2023). Modified-release phosphatidylcholine (LT-02) for ulcerative colitis: Two double-blind, randomized, placebo-controlled trials. Clinical Gastroenterology and Hepatology, 22(4), 810–820.e7. https://doi.org/10.1016/j.cgh.2023.09.031
3. Moe, O. K., Gao, Q., Geng, D., Jensen, E., Goll, R., Nestegard, O., Gundersen, M. D., Meyer, R., Florholmen, J., & Hansen, T. (2025). Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study. BMC Gastroenterology, 25(1), 389. https://doi.org/10.1186/s12876-025-03944-6
4. Schebb, N. H., Kühn, H., Kahnt, A. S., Rund, K. M., O’Donnell, V. B., Flamand, N., Peters-Golden, M., Jakobsson, P.-J., Weylandt, K. H., Rohwer, N., Murphy, R. C., Geisslinger, G., FitzGerald, G. A., Hanson, J., Dahlgren, C., Alnouri, M. W., Offermanns, S., & Steinhilber, D. (2022). Formation, signaling and occurrence of specialized pro-resolving lipid mediators — what is the evidence so far? Frontiers in Pharmacology, 13, 838782. https://doi.org/10.3389/fphar.2022.838782
5. Gurzell, E. A., Wiesinger, J. A., Morkam, C., Hemmrich, S., Harris, W. S., & Fenton, J. I. (2014). Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA+DHA content?. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 91(3), 87-96. https://doi.org/10.1016/j.plefa.2014.04.001
6. Pearl, D. S., Masoodi, M., Eiden, M., Brümmer, J., Gullick, D., McKeever, T. M., Whittaker, M. A., Nitch-Smith, H., Brown, J. F., Shute, J. K., Mills, G., Calder, P. C., & Trebble, T. M. (2013). Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity. Journal of Crohn’s & Colitis, 8(1), 70-79. https://doi.org/10.1016/j.crohns.2013.03.013
7. Hofstetter, R. K., Werner, M., Schädel, P., Wichmann-Costaganna, M., Fischer, K., Bruggink, V., Meyer, K. P. L., Peltner, L., Günther, K., Bachmann, V., Engelbrecht, H., Gutjahr, C., Perkowski, B., Griebel, G., Bal, N. B., Ueberschaar, N., Jordan, P. M., & Werz, O. (2026). Validated bioanalysis of oxylipins confirms specialized pro-resolving mediator formation in vitro and in vivo. Journal of Lipid Research, 67(7), 101075. https://doi.org/10.1016/j.jlr.2026.101075
8. Venn-Watson, S. K., Parry, C., Baird, M., Stevenson, S., Carlin, K., Daniels, R., Smith, C. R., Jones, R., Wells, R. S., Ridgway, S., & Jensen, E. D. (2015). Increased dietary intake of saturated fatty acid heptadecanoic acid (C17:0) associated with decreasing ferritin and alleviated metabolic syndrome in dolphins. PLoS ONE, 10(7), e0132117. https://doi.org/10.1371/journal.pone.0132117
9. Imamura, F., Fretts, A., Marklund, M., Ardisson Korat, A. V., Yang, W.-S., Lankinen, M., Qureshi, W., Helmer, C., Chen, T.-A., Wong, K., Bassett, J. K., Murphy, R., Tintle, N., Yu, C. I., Brouwer, I. A., Chien, K.-L., Frazier-Wood, A. C., Del Gobbo, L. C., Djoussé, L., … Mozaffarian, D. (2018). Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLoS Medicine, 15(10), e1002670. https://doi.org/10.1371/journal.pmed.1002670
10. Venn-Watson, S. (2024). The cellular stability hypothesis: Evidence of ferroptosis and accelerated aging-associated diseases as newly identified nutritional pentadecanoic acid (C15:0) deficiency syndrome. Metabolites, 14(7), 355. https://doi.org/10.3390/metabo14070355

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 8 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.